J NEUTEL

1.5k total citations
61 papers, 1.0k citations indexed

About

J NEUTEL is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, J NEUTEL has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 22 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Surgery. Recurrent topics in J NEUTEL's work include Blood Pressure and Hypertension Studies (42 papers), Hormonal Regulation and Hypertension (20 papers) and Heart Rate Variability and Autonomic Control (13 papers). J NEUTEL is often cited by papers focused on Blood Pressure and Hypertension Studies (42 papers), Hormonal Regulation and Hypertension (20 papers) and Heart Rate Variability and Autonomic Control (13 papers). J NEUTEL collaborates with scholars based in United States, Germany and France. J NEUTEL's co-authors include David H.G. Smith, Michael A. Weber, William F. Graettinger, Suzanne Oparil, Richard A. Preston, D KASS, George L. Bakris, A Bank, Yves Lacourcière and Bruce Lachterman and has published in prestigious journals such as Circulation, Journal of the American Society of Nephrology and Clinical Chemistry.

In The Last Decade

J NEUTEL

58 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J NEUTEL United States 19 808 329 144 126 72 61 1.0k
Hirotoshi Ohmura Japan 21 356 0.4× 317 1.0× 317 2.2× 106 0.8× 51 0.7× 43 963
Domenico Galzerano Italy 18 585 0.7× 275 0.8× 163 1.1× 177 1.4× 96 1.3× 72 1.2k
Charn Sriratanasathavorn Thailand 12 596 0.7× 139 0.4× 124 0.9× 37 0.3× 53 0.7× 34 906
Chang‐Sheng Sheng China 18 644 0.8× 175 0.5× 177 1.2× 90 0.7× 15 0.2× 76 970
M Stuehlinger Austria 10 545 0.7× 151 0.5× 111 0.8× 150 1.2× 25 0.3× 17 1000
B. Waeber Switzerland 21 665 0.8× 272 0.8× 124 0.9× 135 1.1× 33 0.5× 67 1.3k
A. E. Doyle Australia 19 494 0.6× 318 1.0× 186 1.3× 96 0.8× 37 0.5× 76 1.3k
William Chung United States 8 322 0.4× 175 0.5× 109 0.8× 78 0.6× 31 0.4× 19 1.0k
Yuji Hirai Japan 16 252 0.3× 198 0.6× 138 1.0× 115 0.9× 41 0.6× 23 802
Luca Corradi Italy 22 976 1.2× 470 1.4× 206 1.4× 84 0.7× 13 0.2× 66 1.3k

Countries citing papers authored by J NEUTEL

Since Specialization
Citations

This map shows the geographic impact of J NEUTEL's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J NEUTEL with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J NEUTEL more than expected).

Fields of papers citing papers by J NEUTEL

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J NEUTEL. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J NEUTEL. The network helps show where J NEUTEL may publish in the future.

Co-authorship network of co-authors of J NEUTEL

This figure shows the co-authorship network connecting the top 25 collaborators of J NEUTEL. A scholar is included among the top collaborators of J NEUTEL based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J NEUTEL. J NEUTEL is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Bryan, Yves Lacourcière, Helmut Schumacher, Philippe Gosse, & J NEUTEL. (2009). Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials. Journal of Human Hypertension. 23(9). 610–619. 26 indexed citations
2.
Franklin, Stanley S. & J NEUTEL. (2008). Initial combination therapy for rapid and effective control of moderate and severe hypertension. Journal of Human Hypertension. 23(1). 4–11. 12 indexed citations
3.
Cohn, Jay N., Daniel J. Wilson, J NEUTEL, et al.. (2008). Coadministered Amlodipine and Atorvastatin Produces Early Improvements in Arterial Wall Compliance in Hypertensive Patients With Dyslipidemia. American Journal of Hypertension. 22(2). 137–144. 32 indexed citations
4.
NEUTEL, J, Stanley S. Franklin, Pablo Lapuerta, Amitabha Bhaumik, & Agata Ptaszynska. (2007). A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension. Journal of Human Hypertension. 22(4). 266–274. 28 indexed citations
5.
NEUTEL, J, et al.. (2006). Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension. Journal of Human Hypertension. 20(4). 255–262. 30 indexed citations
6.
Lacourcière, Yves, et al.. (2006). A Multicenter, 14-Week Study of Telmisartan and Ramipril in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring. American Journal of Hypertension. 19(1). 104–112. 56 indexed citations
7.
Flack, J., et al.. (2004). EFFICACY AND SAFETY OF ATORVASTATIN PLUS AMLODIPINE VERSUS EITHER AGENT ALONE IN PATIENTS WITH CONCOMITANT DYSUPIDEMIA AND HYPERTENSION. Journal of Hypertension. 22(Suppl. 1). S12–S12. 6 indexed citations
8.
NEUTEL, J. (2004). Effect of the renin–angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. Journal of Human Hypertension. 18(9). 599–606. 44 indexed citations
9.
NEUTEL, J. (2004). Dual goal attainment with amlodipine/atorvastatin single pill in a broad range of patients: results from the gemini study. American Journal of Hypertension. 17(5). S184–S184. 4 indexed citations
10.
NEUTEL, J, et al.. (2003). Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension—a randomised ABPM study. Journal of Human Hypertension. 17(8). 569–575. 22 indexed citations
11.
Messerli, Franz H., et al.. (2002). Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting. American Journal of Hypertension. 15(6). 550–556. 37 indexed citations
12.
NEUTEL, J. (2001). Beyond the sphygmomanometric numbers: hypertension as a syndrome. American Journal of Hypertension. 14(8). S250–S257. 10 indexed citations
13.
NEUTEL, J. (1999). Low-dose antihypertensive combination therapy: its rationale and role in cardiovascular risk management. American Journal of Hypertension. 12(4). 73–79. 31 indexed citations
14.
NEUTEL, J. (1999). Is high blood pressure a late manifestation of the hypertension syndrome?. American Journal of Hypertension. 12(4). 215–223. 22 indexed citations
15.
NEUTEL, J, et al.. (1998). Hypertension: Where have we gone wrong and how can we fix it?. American Journal of Hypertension. 11(10). 150S–157S. 8 indexed citations
16.
Smith, David H.G., J NEUTEL, Henry R. Black, James A. Schoenberger, & M. A. Weber. (1996). Once-daily monotherapy with trandolapril in the treatment of hypertension.. PubMed. 10(2). 129–34. 10 indexed citations
17.
NEUTEL, J. (1996). Role of Whole-Day Ambulatory Blood Pressure Monitoring in the Management of Hypertension. American Journal of Nephrology. 16(3). 202–209. 4 indexed citations
18.
NEUTEL, J, et al.. (1993). The relationship of arterial compliance with endothelial-derived proteins of the hemostatic system. Life Sciences. 52(12). 1005–1011. 9 indexed citations
19.
Weber, Michael A., David H.G. Smith, J NEUTEL, & Deanna G. Cheung. (1991). Applications of ambulatory blood pressure monitoring in clinical practice. Clinical Chemistry. 37(10). 1880–1884. 3 indexed citations
20.
Cheung, Deanna G., et al.. (1990). Absence of placebo effect on the whole day ambulatory blood pressure bp. Clinical Pharmacology & Therapeutics. 47(2). 200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotoshi Ohmura Breakdown of academic impact, for papers by Domenico Galzerano Breakdown of academic impact, for papers by Charn Sriratanasathavorn Breakdown of academic impact, for papers by Chang‐Sheng Sheng Breakdown of academic impact, for papers by M Stuehlinger Breakdown of academic impact, for papers by B. Waeber Breakdown of academic impact, for papers by A. E. Doyle Breakdown of academic impact, for papers by William Chung Breakdown of academic impact, for papers by Yuji Hirai Breakdown of academic impact, for papers by Luca Corradi
Rankless by CCL
2026